Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Meghan Kunchai"'
Autor:
Mary E. Enama, Pamela Costner, Galina Yamshchikov, Ingelise J. Gordon, Michelle Conan-Cibotti, Phyllis Renehan, Meghan Kunchai, Cynthia S. Hendel, Alisha Kabadi, Floreliz Mendoza, LaSonji A. Holman, Donald M. Poretz, Jamie G. Saunders, Zonghui Hu, Julie E. Ledgerwood, Laura Novik, Robert T. Bailer, Uzma N. Sarwar, John R. Mascola, Barry A. Eagel, Judith Starling, Sarah H. Plummer, Olga Vasilenko, Sandra Sitar, Kathryn L Zephir, Hope Decederfelt, Barney S. Graham, Sheryl Young, Diane Johnson, Joseph P. Casazza, Richard N. Jones, Richard A. Koup, Ly Diep, Charla Andrews, Brenda Larkin
Publikováno v:
Contemporary clinical trials. 44
Annual influenza vaccination reduces the risks of influenza when the vaccines are well matched to circulating strains, but development of an approach that induces broader and more durable immune responses would be beneficial. We conducted two compani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a78e2d7ebe87a5bf46de899d7f0804
https://pubmed.ncbi.nlm.nih.gov/26275339
https://pubmed.ncbi.nlm.nih.gov/26275339
Autor:
Dan H. Barouch, Shringkhala Bajimaya, Raphael Dolin, Chelsea Bleckwehl, Avinash Oza, Brian A. Engelson, Jane A. Kleinjan, Meghan Kunchai, Stephen R. Walsh, Peter Abbink, Michael S. Seaman, Lauren Peter, Robert Tucker, Mark Wolff, Jon A Gothing, Brittany R. Carey, Edith Swann, Lindsey R. Baden, Mo Weijtens, Maria G. Pau, Jennifer Johnson
Publikováno v:
The Journal of infectious diseases. 210(7)
Development of a preventive human immunodeficiency virus 1 (HIV-1) vaccine is a global health priority, but to our knowledge only 4 vaccine concepts have been evaluated in field trials to date [1–7]. Adenoviruses are potent vectors [8], and althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680a5da1baa3753d346f93e4d7578ba2
https://pubmed.ncbi.nlm.nih.gov/24719474
https://pubmed.ncbi.nlm.nih.gov/24719474